Fish oil-derived fatty acids during pregnancy and risk of neurodevelopmental disorders in children at age 10 - A randomized controlled trial
Open Access
- 2 July 2026
- journal article
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Abstract
Fish oil-derived omega-3 fatty acids (ꙍ-3 FA), particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are critical for early brain development, but evidence of causal effects from supplementation during pregnancy is limited. In the prospective COPSAC2010 cohort of 700 mother-child pairs, we investigated whether i) maternal DHA + EPA blood concentrations in mid-pregnancy and ii) fish oil supplementation in a randomized trial in late pregnancy influence neurodevelopmental outcomes at age 10. Maternal blood DHA + EPA concentrations were measured at 24 weeks gestation, followed by randomization to 2.4 g daily fish oil (37% DHA, 55% EPA) or placebo until one-week postpartum. Psychopathology was assessed in the children at age 10 using the Kiddie Schedule for Affective Disorders and Schizophrenia -Present and Lifetime version and parental-rated questionnaires Statistical analyses included logistic and linear regression models. Higher maternal DHA + EPA concentrations were associated with reduced ADHD risk (OR 0.71, p = 0.03) and ADHD symptom load (β = -1.14, p < 0.001) in unadjusted analyses but not after confounder adjustment (OR 0.82, p = 0.24; β = -0.49, p = 0.21). Similar trends were observed for autistic traits (β = -1.96, [-1.11; -0.24] p = 0.01), but not significant after confounder adjustment. Fish oil supplementation showed no significant reduction in ADHD (OR 0.79, p = 0.37) or ASD risk (OR 0.56, p = 0.42). A secondary analysis suggested a protective effect for ADHD Predominantly Inattentive Presentation, although it did not hold significance after correction for multiple testing (OR 0.41; p = 0.03; FDRp=0.12). Thus, potential effects on inattentive ADHD symptoms should be explored in future studies.Funding Information
- Lundbeck Foundation (R269-2017-5)
- Lundbeck Foundation (R269-2017-5)
- Lundbeck Foundation (R269-2017-5)
- Lundbeck Foundation (R269-2017-5)
- Lundbeck Foundation (R269-2017-5)
- Horizon 2020 Framework Programme (946228)
This publication has 33 references indexed in Scilit:
- High-dose vitamin D3 supplementation in pregnancy and risk of neurodevelopmental disorders in the children at age 10: A randomized clinical trialThe American Journal of Clinical Nutrition, 2023
- Types of fish consumption differ across socioeconomic strata and impact differently on plasma fish-based omega-3 fatty acids: a cross-sectional studyEuropean Journal of Nutrition, 2023
- Prenatal Omega-6:Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder SymptomsThe Journal of Pediatrics, 2019
- Prenatal n-3 Long-Chain Polyunsaturated Fatty Acids and Children’s Executive Functions2019
- Omega-3 fatty acid addition during pregnancyCochrane Database of Systematic Reviews, 2018
- Plasma Concentrations of Long Chain N-3 Fatty Acids in Early and Mid-Pregnancy and Risk of Early Preterm BirthEBioMedicine, 2018
- Effect of Vitamin D3Supplementation During Pregnancy on Risk of Persistent Wheeze in the OffspringJAMA, 2016
- Food for thought: Dietary changes in essential fatty acid ratios and the increase in autism spectrum disordersNeuroscience & Biobehavioral Reviews, 2014
- Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort studyThe Lancet, 2007
- Tissue levels of polyunsaturated fatty acids during early human developmentThe Journal of Pediatrics, 1992